Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194311 · ClinicalTrials.gov registry record
Human Papillomavirus (HPV) Infection in Pregnancy
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 620
- Enrollment target
NCT00194311: Completed study, sponsored by University of Pennsylvania.
NCT00194311 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 620 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194311 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 620 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if maternal infection with human papillomavirus (HPV) is associated with pregnancy complications including spontaneous preterm delivery (sPTD), severe preeclampsia (PE), and poor fetal growth.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 620 participants |
| Start Date | 2005-04 |
| Est. Completion | 2007-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194311
The ClinicalTrials.gov registry entry for NCT00194311 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 620 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00194311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194311 about?
NCT00194311 is a clinical study titled "Human Papillomavirus (HPV) Infection in Pregnancy". The purpose of this study is to determine if maternal infection with human papillomavirus (HPV) is associated with pregnancy complications including spontaneous preterm delivery (sPTD), severe preeclampsia (PE), and poor fetal growth.
What is the current status of trial NCT00194311?
This trial is currently completed. The enrollment target is 620 participants. The study started on 2005-04. Estimated completion is 2007-08.
Who is sponsoring clinical trial NCT00194311?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.